The 20 Best Follicular Lymphoma Doctors near Pittsburgh, PA

Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Jing-Zhou Hou, MD, PhD, is a clinical hematological oncologist specializing in hematological malignancies, cell therapy, and bone marrow transplant in the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center. Dr. Hou received his medical degree from Henan Medical University in China, his master’s degree at Shanghai Medical University, and his PhD in Molecular and Cell Biology from Tulane University. He completed his internal medicine residency in Northeastern Ohio University College of Medicine, and fellowship in Hematology and Oncology at Stanford University. He joined UPMC Hillman Cancer Center in 2007. Dr. Hou is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

James M. Rossetti, DO, is a hematologist specializing in the treatment of hematological malignancies and myeloid diseases, including myelodysplasia, acute myeloid leukemia, and myeloproliferative neoplasm. He also specializes in cellular therapy. Dr. Rossetti is a referral physician for the UPMC MDS Center of Excellence. Dr. Rossetti is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

Melissa K. Yee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center.  She specializes in the treatment of solid tumors and blood disorders.Dr. Yee is board-certified by the American Board of Internal Medicine in medical oncology, hematology, and internal medicine.  She received her medical degree from the Drexel University College of Medicine in Philadelphia. She then completed her internal medicine residency and hematology/oncology fellowship at UPMC. She earned her undergraduate degree from Tufts University. After completion of her medical training, she was on staff at Dana Farber Cancer Institute in Boston before returning to Pittsburgh to practice at UPMC Mercy.Dr. Yee is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology, and Massachusetts Medical Society. Dr. Yee is rated as an Experienced provider by MediFind in the treatment of Follicular Lymphoma. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and Pleuropulmonary Blastoma.

Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. Dr Smith specializes in bleeding and thrombotic disorders, Rare Homologic Diseases, Chronic Leukemia and Myelodyplasia.Dr. Smith is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from The Ohio State University, Columbus, and his Master of Science degree from the University of Wisconsin, College of Medicine, Madison. He completed his residency in medical oncology and his fellowship in hematology oncology, both at The Ohio State University. He is the former director of the Ohio State University Hospital's Special Coagulation Laboratory and its Hemophilia Center. He presently serves as chairman of the Central Investigational Review Board for the Cancer Therapeutics and Development branch of the National Cancer Institute and has served on the Peripheral and Central Nervous System Drug Advisory Committee and the Oncologic Drug Advisory Committee of the FDA. Dr. Smith serves as the co-chair of the Anticoagulation Task Force for the Presbyterian Hospital and its affiliates and chair of the Anticoagulation Working Group of the system-wide P and T committee.Dr. Smith is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Society for Scientific Exploration, The International Society of Thrombosis and Hemostasis, the American Medical Association and the American Society for Apheresis, and the American College of Chest Physicians. He is a Fellow of the American College of Physicians and the International Academy of Clinical and Applied Thrombosis and Hemostasis. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Venous Thromboembolism (VTE), Acute Hepatic Porphyria (AHP), Shwartzman Phenomenon, Pulmonary Embolism, and Bone Marrow Aspiration.

Kathleen Dorritie, MD, is a hematologist/medical oncologist at UPMC Hillman Cancer Center specializing in hematologic malignancies and stem cell transplantation. Her research focuses on early phase clinical trials for lymphoid malignancies. She has been very involved in the development of the CAR T-cell program at UPMC and has also worked to develop a stem cell transplant program for hemoglobinopathies, including sickle cell disease. Dr. Dorritie is rated as an Experienced provider by MediFind in the treatment of Follicular Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors. Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.

Kelly G. Ross, MD, specializes in hematology oncology and is board-certified in hematolgoy and medical oncology by the American Board of Internal Medicine. She is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ross completed her fellowship at the University of Colorado and residency and medical degree at the University of Pittsburgh School of Medicine. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Follicular Lymphoma. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Robert Redner is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Redner is currently accepting new patients.

Kiran Kumar Rajasenan, MD, is a medical oncologist at UPMC Hillman Cancer Center, Wexford. Board-certified in internal medicine and medical oncology, Dr. Rajasenan received his medical degree from Hahnemann Medical College, now Drexel University College of Medicine in Philadelphia. He completed his residency at Allegheny General Hospital in Pittsburgh. Dr. Rajasenan is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma.

Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma.

Sushil Beriwal is a Radiation Oncologist in Pittsburgh, Pennsylvania. Dr. Beriwal is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Vaginal Cancer, Vulvar Cancer, Endometrial Cancer, Vulvectomy, and Orchiectomy.

Chirag Shah is an Oncologist in Pittsburgh, Pennsylvania. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Breast Cancer, Intraductal Papilloma, HER-2 Positive Breast Cancer, and Triple-Negative Breast Cancer.

Philip Symes is a Hematologist in Pittsburgh, Pennsylvania. Dr. Symes is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, Familial Pancreatic Cancer, and Bone Marrow Aspiration.

John Lister is a Hematologist in Pittsburgh, Pennsylvania. Dr. Lister is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Cyrus Khan is a Hematologist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Chronic B-Cell Leukemia (CBCL), Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Aspiration, and Bone Marrow Transplant.

Alexander Barsouk is a Hematologist in Pittsburgh, Pennsylvania. Dr. Barsouk is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Gastroesophageal Junction Cancer, and Colorectal Cancer.

Radhakrishnan Ramchandren is a Hematologist in Pittsburgh, Pennsylvania. Dr. Ramchandren is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Mounzer Agha is a Hematologist in Pittsburgh, Pennsylvania. Dr. Agha is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Felicia Snead, MD, is the medical director of St. Clair Hospital Cancer Center, Radiation Oncology, affiliated with UPMC Hillman Cancer Center and is a clinical associate professor in the Department of Radiation Oncology at the University of Pittsburgh School of Medicine. She treats all radiation oncology cases. Dr. Snead is rated as an Experienced provider by MediFind in the treatment of Follicular Lymphoma. Her top areas of expertise are Nasopharyngeal Carcinoma, Breast Cancer, Pleuropulmonary Blastoma, and Familial Pancreatic Cancer.